A Phase 2, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety, and Tolerability of Oral Omadacycline in Adult Subjects with Nontuberculous Mycobacterial (NTM) Pulmonary Disease Caused by Mycobacterium abscessus complex (MABc)
Research Grant Start Date:
06/01/2021
Research Topics:
Research Lead Investigators:
Research Summary
To evaluate the efficacy of omadacycline in adult subjects with Nontuberculous Mycobacterial (NTM) pulmonary disease caused by Mycobacterium abscessus complex (MABc) based upon subject assessment of symptoms